The Food and Drug Administration will ask outside experts next week whether the diabetes drug Avandia should carry label warnings of heart attack risk.

Up until this past month, I had no idea that Avandia had anything to do with my heart problem. A friend saw something on TV about Avandia and its link to heart attacks.

Rosiglitazone is widely used to treat patients with type 2 diabetes mellitus, but its effect on cardiovascular morbidity and mortality has not been determined.

The government's own preliminary evaluation of the diabetes pill Avandia confirms the heart risks reported in a study earlier this week and suggests that as many as 60,000 to 100,000 heart attacks might be linked to its use since it came on the market eight years ago.

FDA informed healthcare professionals of a potential safety issue related to Avandia (rosiglitazone).